Overview

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects on the kidney of rosuvastatin and simvastatin in subjects with Fredrickson Type IIa & Type IIb Dyslipidaemia
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Lipid Regulating Agents
Rosuvastatin Calcium
Simvastatin